Document is current
Any future updates will be listed below
-
Authors
Kawamura, Chitose
Bhaskaran, Krishnan
Konishi, Takaaki
Sagara, Yasuaki
Bando, Hiroko
Shinozaki, Tomohiro
Nojiri, Shuko
Adomi, Motohiko
Wong, Angel Y. S.
Tamiya, Nanako
Iwagami, Masao https://orcid.org/0000-0001-7079-0640
-
Funding
Funding for this research was provided by:
Pfizer Health Research Foundation
- License Information
-
More Information
Article History
Received: 10 June 2025
Accepted: 20 August 2025
First Online: 27 August 2025
Declarations
:
: KB was funded by a Wellcome Senior Research Fellowship (220283/Z/20/Z). TK has received grants from the Kanzawa medical research foundation and the Japan Kampo medicines manufacturers association. YS has received honoraria from Pfizer, Astra Zeneca, Daiichi Sankyo, Eisai, Eli Lily, Chugai, MSD, Nippon Kayaku, Kyowa Kirin, Sysmex, and Celltrion healthcare Japan. TS has received consultation fees from Takeda Pharmaceutical Co., Ltd. and TMP medical, and lecture fees from Chugai Pharmaceutical Co., Ltd., Novartis, Pfizer Japan, SAS institute Japan, CMIC HOLDINGS Co., LTD, and Santen Pharmaceutical Co., Ltd. AW has received honoraria from Henry Stewart Talk, 6th Annual meeting of the Society for Clinical Epidemiology in Tokyo, and 28th Annual Meeting of the Japanese Society for Pharmacoepidemiology. Other authors declare no competing interests.
: We obtained data from the JMDC Inc., and we are not allowed to share these data with other parties. Researchers who meet the criteria for access can acquire de-identified participant data from the JMDC Inc. ().
